The moral price we pay for “innovation”
Our willingness to turn a blind eye to the profiteering of biotech is a moral failing, writes Dr. Vikas Saini in a Commonhealth op-ed.
Read More
All News In the News News Releases
Our willingness to turn a blind eye to the profiteering of biotech is a moral failing, writes Dr. Vikas Saini in a Commonhealth op-ed.
Read More
Will routine genomic sequencing be the innovation that revolutionizes medicine? Or is it more hype than substance?
Read More
A new study sheds finds that benzodiazepine are being increasingly prescribed chronic pain and long-term use, which may have harmful consequences.
Read More
A new study shows that in pharmaceutical marketing, the number of doctors you target may matter more than the amount of money you give them.
Read More
Do FDA rules make it too difficult for new diagnostic tests to be approved? Or is it too easy?
Read More
The cost-benefit equation for lung cancer screening is missing a significant type of cost…
Read More
Physician burnout appears to be getting worse. These doctors are sending a call to action to address the problem.
Read More
A new study finds that observable physician characteristics don’t help much in explaining overuse. Then what could be the explanation?
Read More
Why can’t we get better price transparency for health care services in hospitals? Because the “real” price doesn’t exist…
Read More
The Reimagine Medicine program started with an artist with a long experience of illness and a doctor with a long fascination with storytelling. Together, Ray Barfield and Marina Tsaplina are ready to transform medical education.
Read More